Literature DB >> 28574057

New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles.

M A Zaimy1, N Saffarzadeh1, A Mohammadi2, H Pourghadamyari3, P Izadi1, A Sarli4, L K Moghaddam5, S R Paschepari5, H Azizi6, S Torkamandi7, J Tavakkoly-Bazzaz1.   

Abstract

Cancer is one of the leading cause of death in the world with the prevalence of >10 million mortalities annually. Current cancer treatments include surgical intervention, radiation, and taking chemotherapeutic drugs, which often kill the healthy cells and result in toxicity in patients. Therefore, researchers are looking for ways to be able to eliminate just cancerous cells. Intra-tumor heterogeneity of cancerous cells is the main obstacle on the way of an effective cancer treatment. However, better comprehension of molecular basis of tumor and the advent of new diagnostic technologies can help to improve the treatment of various cancers. Therefore, study of epigenetic changes, gene expression of cancerous cells and employing methods that enable us to correct or minimize these changes is critically important. In this paper, we will review the recent advanced strategies being used in the field of cancer research.

Entities:  

Mesh:

Year:  2017        PMID: 28574057     DOI: 10.1038/cgt.2017.16

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  106 in total

Review 1.  Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.

Authors:  R K Jain
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

Review 2.  Small-scale systems for in vivo drug delivery.

Authors:  David A LaVan; Terry McGuire; Robert Langer
Journal:  Nat Biotechnol       Date:  2003-10       Impact factor: 54.908

Review 3.  Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?

Authors:  J Weiler; J Hunziker; J Hall
Journal:  Gene Ther       Date:  2006-03       Impact factor: 5.250

4.  Surface modification of tri-calcium phosphate nanoparticles by DOPE and/or anti-E6 antibody to enhance uptake of antisense of E6 mRNA.

Authors:  Ali Jebali; Seyed Mehdi Kalantar; Seyedhossein Hekmatimoghaddam; Negin Saffarzadeh; Mohammad Hassan Sheikha; Nasrin Ghasemi
Journal:  Colloids Surf B Biointerfaces       Date:  2015-01-03       Impact factor: 5.268

5.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

Review 6.  MiRNAs and cancer.

Authors:  Rosa Visone; Carlo M Croce
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

Review 7.  Epigenetic modifications as therapeutic targets.

Authors:  Theresa K Kelly; Daniel D De Carvalho; Peter A Jones
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

8.  Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer.

Authors:  Timothy M Zagar; Zeljko Vujaskovic; Silvia Formenti; Hope Rugo; Franco Muggia; Brigid O'Connor; Robert Myerson; Paul Stauffer; I-Chow Hsu; Chris Diederich; William Straube; Mary-Keara Boss; Alina Boico; Oana Craciunescu; Paolo Maccarini; David Needham; Nicholas Borys; Kimberly L Blackwell; Mark W Dewhirst
Journal:  Int J Hyperthermia       Date:  2014-08       Impact factor: 3.914

Review 9.  Current prospects for RNA interference-based therapies.

Authors:  Beverly L Davidson; Paul B McCray
Journal:  Nat Rev Genet       Date:  2011-05       Impact factor: 53.242

10.  RNA interference for the treatment of papillomavirus disease.

Authors:  Richa Singhania; Norliana Khairuddin; Daniel Clarke; Nigel Aj McMillan
Journal:  Open Virol J       Date:  2012-12-28
View more
  21 in total

Review 1.  SIX3 function in cancer: progression and comprehensive analysis.

Authors:  Tian-Liang Ma; Peng Zhu; Jing-Xian Chen; Yi-He Hu; Jie Xie
Journal:  Cancer Gene Ther       Date:  2022-06-28       Impact factor: 5.987

2.  Decoding the multidimensional signatures of resident and expanded natural killer cells generated from perinatal blood.

Authors:  Leisheng Zhang; Min Liu; Baoquan Song; Wenjing Miao; Rucai Zhan; Sijun Yang; Zhihai Han; Hui Cai; Xianghong Xu; Yixiao Zhao; Zhongchao Han; Tiankang Guo; Jun Yao; Qing Huang
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

3.  Probing Vasoreactivity and Hypoxic Phenotype in Different Tumor Grafts Grown on the Chorioallantoic Membrane of the Chicken Embryo In Ovo Using MRI.

Authors:  Johanna Buschmann; Dorothea M Heuberger; Fatma Kivrak Pfiffner; Petra Wolint; Jae-Hwi Jang; Wolfgang Jungraithmayr; Pietro Giovanoli; Maurizio Calcagni; Conny F Waschkies
Journal:  Cancers (Basel)       Date:  2022-06-25       Impact factor: 6.575

4.  Targeting Transcription Factors in Cancer: From "Undruggable" to "Druggable".

Authors:  Zhipeng Tao; Xu Wu
Journal:  Methods Mol Biol       Date:  2023

Review 5.  Nanoparticles-Emerging Potential for Managing Leukemia and Lymphoma.

Authors:  Raquel Vinhas; Rita Mendes; Alexandra R Fernandes; Pedro V Baptista
Journal:  Front Bioeng Biotechnol       Date:  2017-12-18

Review 6.  Diagnostic and Prognostic Value of Circulating CircRNAs in Cancer.

Authors:  Mina Wang; Feiyu Xie; Jiaran Lin; Yihan Zhao; Qian Zhang; Zehuan Liao; Peng Wei
Journal:  Front Med (Lausanne)       Date:  2021-03-18

Review 7.  Nanoparticles use for Delivering Ursolic Acid in Cancer Therapy: A Scoping Review.

Authors:  Andang Miatmoko; Ester Adelia Mianing; Retno Sari; Esti Hendradi
Journal:  Front Pharmacol       Date:  2021-12-24       Impact factor: 5.810

8.  Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects.

Authors:  Xinrong Lin; Xiaosong Xiang; Bing Feng; Hao Zhou; Ting Wang; Xiaoyuan Chu; Rui Wang
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

9.  Probing the Electron Transfer between iLOV Protein and Ag Nanoparticles.

Authors:  Xia Ran; Qianqian Zhang; Yu Zhang; Jin Chen; Zhongran Wei; Yulu He; Lijun Guo
Journal:  Molecules       Date:  2020-05-29       Impact factor: 4.411

Review 10.  Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers.

Authors:  Luying He; Zhangfeng Zhong; Man Chen; Qilian Liang; Yitao Wang; Wen Tan
Journal:  Front Pharmacol       Date:  2022-01-03       Impact factor: 5.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.